KERYX BIOPHARMACEU (NASDAQ:KERX)

2.30

0.05 (2.13%)

KERYX BIOPHARMACEU (NASDAQ:KERX) Delayed :
Previous Close	$2.35	52 Week High	$3.33
Open	$2.35	52 Week Low	$0.09
Day High	$2.37	P/E	9.20
Day Low	$2.25	EPS	$0.25
Volume	631,239
More KERX Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
AEZS	11	AEZ	5
ANPI	3	ONTY	3
MITI	3	GPRE	2
TSPT	2	ATCO	2
AMFI	2	DIET	2
YRCW	2	OGXI	2

View All Entities

Nov 10, 2009 08:04 AM Keryx Biopharma (KERX) Posts Q3 EPS of 1c, Beats by 10c
May 14, 2009 09:00 AM Keryx Biopharmaceuticals (KERX) Swings to Q1 Profit
Mar 12, 2009 05:01 PM Keryx Biopharmaceuticals (KERX) Tops Q4 EPS by 5c; CEO Comments on Outlook

Nov 11, 2009 08:58 AM AEterna Zentaris (AEZS) Reports That Perifosine Partner Keryx Biopharma (KERX) Will Prersent Data from Phase 1/2 at 51st ASH Meeting
Nov 10, 2009 08:04 AM Keryx Biopharma (KERX) Posts Q3 EPS of 1c, Beats by 10c
Nov 9, 2009 02:36 PM Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
Nov 9, 2009 09:04 AM AEterna Zentaris (AEZS) Announces Publication of PI3K/Akt Article in Journal of Urology
Oct 8, 2009 09:07 AM Keryx Bio (KERX) Announces Perifosine Phase 2 for Chronic and Small Lymphocytic Leukemia

Nov 11, 2009 08:35AM AEterna Zentaris Partner, Keryx Biopharmaceuticals, Announces Poster Presentation Highlighting Clinical Activity of Perifosine (KRX-0401) at 51st Annual Meeting of the American Society of Hematology
Nov 11, 2009 08:30AM Keryx Biopharmaceuticals Announces Poster Presentation Highlighting Clinical Activity of KRX-0401 (Perifosine) at the 51st Annual Meeting of the American Society of Hematology
Nov 9, 2009 04:30PM Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
Nov 9, 2009 07:00AM AEterna Zentaris: Scientific Article Supports Perifosine's Development in Kidney Cancer
Nov 6, 2009 08:30AM Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2009 Financial Results on Tuesday, November 10, 2009 at 8:30 a.m. EST

Oct 27, 2009 06:14 AM Keryx Biopharmaceuticals' Next Price Movers Will Be Trial News
Oct 9, 2009 07:05 AM Keryx Biopharma Investors Should Wait for More News on Trials
Oct 4, 2009 07:26 AM Keryx Pharmaceuticals: Time to Buy Back In
Sep 30, 2009 10:57 AM Keryx Pharma Could Turn into a Real Winner Down the Road
Sep 29, 2009 04:31 PM Closing Update for Tuesday, Sept. 29: Dow Fronts Narrow Losses

Nov 10, 2009 05:03PM Form 10-Q KERYX BIOPHARMACEUTICALS For: Sep 30
Nov 9, 2009 05:01PM Form 8-K KERYX BIOPHARMACEUTICALS For: Nov 09
Nov 9, 2009 05:00PM Form 4 KERYX BIOPHARMACEUTICALS For: Nov 07 Filed by: Fowler Wyche JR
Oct 1, 2009 05:15PM Form SC 13G KERYX BIOPHARMACEUTICALS Filed by: Empery Asset Management, LP
Oct 1, 2009 09:57AM Form 8-K KERYX BIOPHARMACEUTICALS For: Sep 25

Huron Ivestigation
on Aug 3, 2009
at 03:40 PM Huron Consulting under investigation Hi All – Thought I’d provide a quick link for any investors reading this piece – I work for a law firm that’s investigating Huron on behalf of investors. You can learn more about the investigation here – www.hbsslaw.com/huron. HBSS is looking into possible issues with over-reported earnings, kickbacks to company insiders, and how and when the company notified shareholders.
Article: Morning Movers 8/3: KERX, TSPT, TSEM, ICAD, AMFI Higher; HURN, RPRX, ADAT, SVNT Lower

No comments are currently available.